Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 29 Sept, 08:00 pm
Analyst Kyle Mikson of Canaccord Genuity raised Grail's price target to $150.00 , up from $80.00 , following recent positive developments. The company's Galleri multi-cancer early detection (MCED) test received a favorable vote from an FDA advisory committee, affirming its safety
Citizens/JMP Securities reiterated a “ Market Outperform ” rating on MongoDB (NASDAQ: MDB) , reflecting confidence ahead of the company’s investor day. Zacks Investment Research upgraded MongoDB to a Zacks Rank #1 (Strong Buy), citing positive earnings estimate
Critical Metals Corp. (NASDAQ: CRML) reported earnings per share (EPS) of -$0.07 , in line with analyst expectations. Quarterly revenue of $1.32 million fell short of the $4.00 million analyst estimate. The company remains unprofitable, with a reported price-to-earnings (P/E) rat
Investment Confidence: Investment firm Goldman Sachs Group, Inc. (NYSE: GS) initiated a "Buy" rating for Geely Automobile Holdings (OTC: GELYF) , signaling a positive outlook for the stock's future price. Strategic EV Partnerships: Geely Automobile Holdings (OTC: GELYF) has forme
AltShares Merger Arbitrage ETF (NYSE Arca: ARB) is an established merger arbitrage ETF. The ETF seeks to track the Water Island Merger Arbitrage USD Hedged Index , which focuses on publicly announced mergers and acquisitions. The ARB ticker can create confusion because Arbitrum (
Market Losers: WidePoint (NYSE American: WYY), Onterris (NYSE: ONT), and Trio-Tech (NASDAQ: TRT) Lead Declines WidePoint Corporation (NYSE American: WYY) experienced a sharp drop after a Government Accountability Office decision related to a Department of Homeland Security contra
Top Stock Gainers: Masonglory (NASDAQ: MSGY), INLIF (NASDAQ: INLF), and Apimeds (NYSE American: APUS) Rally on Company News Masonglory Limited (NASDAQ: MSGY) led market gains , surging more than 300% after attention returned to its share swap agreement to acquire a 20% stake in B
Gerdau S.A. (NYSE: GGB): Steel Producer Shows Solid Fundamentals and Analyst Upside Potential Gerdau S.A. (NYSE: GGB) has shown recent stock strength, although the shares remain exposed to steel-market volatility. The company demonstrates solid financial health, with a reported P
Acadia Pharmaceuticals (NASDAQ: ACAD) Faces Remlifanserin Trial Miss as Analysts Cut Price Targets Analysts lowered price targets for Acadia Pharmaceuticals (NASDAQ: ACAD) after its Phase II RADIANT study for remlifanserin narrowly missed its primary endpoint. Acadia Pharmaceutic
Ivanhoe Electric (NYSE American: IE) Poised for Growth with Strong Copper Project Economics Scotiabank set an analyst price target of $16.00 for Ivanhoe Electric, indicating a potential 54.29% upside from its previous trading price of $10.37. The Santa Cruz Copper Mining Project'
An analyst price target revision for Westlake (NYSE:WLK) still indicates a significant potential upside of 46.27% . Institutional investors, including Bank of America (NYSE:BAC), are actively increasing their stakes in Westlake, signaling growing confidence. Westlake's strategic
Deutsche Bank raised its price target for PayPal to $55.00 , indicating a potential upside for the fintech stock . PayPal announced a new strategic partnership with Meta Platforms, integrating AI for shopping across its merchant network. Despite a recent rally, PayPal's stock has
Assured Guaranty Ltd. (NYSE: AGO) received an analyst upgrade to "Buy" from Roth Capital, despite recent stock price pressure and hitting a new 52-week low. Assured Guaranty Ltd. is involved in the corporate financial restructuring of Brightline Florida, where a subsidiary insure
Legacy Education Inc. (NYSEAMERICAN: LGCY) reported a Q4 2026 earnings per share (EPS) of $0.13 , missing analyst estimates of $0.15 , with quarterly revenue of $20.1 million also slightly below the $20.18 million forecast. Despite the quarterly miss, the company demonstrated rob
Analysts anticipate Carnival Corporation & plc (NYSE: CCL) to report $8.39 billion in revenue and $1.36 EPS for Q3, marking a 4.9% year-over-year decrease with recent downward revisions. The company's stock has declined 27% , largely due to a 30% surge in Brent oil prices, highli
Oklo (NYSE: OKLO) , a pre-revenue nuclear technology company, is actively developing advanced small modular reactors (SMRs) to provide clean energy solutions, particularly for data centers. UBS analysts have set a price target of $41.00 for Oklo, suggesting a potential upside of
UBS maintained a Neutral rating on UiPath and lowered its price target to $15.00 from $19.00 , reflecting caution after the company’s Investor Day and its fiscal 2028 outlook. Needham analyst Scott Berg maintained a Buy rating with a more optimistic $22.00 price targe
Barclays initiated coverage on Ligand Pharmaceuticals (NASDAQ:LGND) with an " Overweight " rating and a $345 price target. The biopharmaceutical company is strategically expanding its royalty portfolio through investments in innovative treatments, including cancer therapies with
Headlines provided by Investing.com